Pfizer will spend $43 billion to buy Seagen and deepen its reach in cancer treatment. The pharmaceutical giant said Monday it will pay $229 per share for Seagen. Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and deliver new solutions to patients by combining the power of Seagen’s antibody-drug conjugate […]